-transparent.png){kind=logo}
Mixed neuroendocrine-non-neuroendocrine neoplasm associated with autoimmune gastritis. 2022
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
Division of Gastroenterology Omi Medica Center Shiga Japan.
A 60-year-old woman presented with a protruding tumor at the anterior wall of the middle gastric body, and she was positive for anti-parietal cells antibodies with elevated serum gastrin level. Final diagnosis was a mixed neuroendocrine-non-neuroendocrine neoplasm consisting of adenocarcinoma (tub1) and neuroendocrine tumor G2 with autoimmune gastritis.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
August 2020,
Internal medicine (Tokyo, Japan),
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
December 2021,
Journal of gastrointestinal and liver diseases : JGLD,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
September 2021,
Journal of gastrointestinal cancer,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
February 2022,
Clinical journal of gastroenterology,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
January 2024,
Gene,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
May 2019,
Diagnostic pathology,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
November 2021,
Diagnostic pathology,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
January 2021,
Case reports in oncology,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
April 2020,
Pathology, research and practice,
Naoko Mori, and
Masanori Hongo, and
Shizuki Takemura, and
Yoshihiko Sugitani, and
Fumiyasu Nakamura, and
Masaji Tani, and
Atsushi Nishida, and
Osamu Inatomi, and
Akira Andoh, and
Hiromitsu Ban
January 2022,
Case reports in gastroenterology,
